Paul R. Edick, Director of Vistagen Therapeutics VTGN, has filed 1 purchase and 0 sales on the open market. The latest trade was on 25/10/27.

PE

PE

Paul R. Edick

Director

Company

Vistagen Therapeutics VTGN

First filing

23/02/01

Trades

5 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

25/10/27

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Xeris Biopharma HoldingsXERS	Open-market buy	23/08/09	23/08/09	10,000 sh	$2.38	$23,800	+0.4%